Aldose reductase inhibitors for the treatment of diabetic polyneuropathy-Reference-Cited by-同舟云学术

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

Published:2007-10-17 Issue:1 Volume:2010 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chalk Colin¹,Benstead Tim J²,Moore Fraser³

Affiliation:

1. McGill University; Medicine and Neurology & Neurosurgery; Montreal General Hospital - Room L7-313 1650 Cedar Avenue Montreal Quebec Canada H3G 1A4

2. Dalhousie University/Capital Health; Medicine; Room 3828 Halifax Infirmary, 1796 Summer Street Halifax Nova Scotia Canada B3H 3A7

3. McGill University; Department of Neurology and Neurosurgery; Jewish General Hospital 3755 chemin Cote-Ste-Catherine, Room E-005 Montreal Quebec Canada H3T 1E2

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004572.pub2/fullpdf

Reference63 articles.

1. Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients;Baba;Journal of the Peripheral Nervous System,2006

2. The efficacy and safety of the aldose-reductase inhibitor tolrestat in the treatment of chronic sensorimotor diabetic neuropathy;Boulton;Diabetologia,1989

3. A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy;Boulton;Diabetologia,1990

4. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population;Brown;Diabetes Care,2004

5. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)]. [Danish];Christensen;Ugeskrift for Laeger,1987

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selectivity challenges for aldose reductase inhibitors: A review on comparative SAR and interaction studies;Journal of Molecular Structure;2024-12

2. Acupoint prescriptions, treatment protocol and outcome evidence for acupuncture in diabetic peripheral neuropathy: A scoping review of clinical studies;European Journal of Integrative Medicine;2024-09

3. Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study;Diabetes & Metabolism;2024-07

4. Novel drugs affecting diabetic peripheral neuropathy;IRAN J BASIC MED SCI;2024

5. Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options;Journal of Pain Research;2024-03